Ultrasound imaging company SuperSonic Imagine S.A. raised €34.5 million, or $45.3 million, in a Series C financing round.
The funding will support the international commercial expansion of the Aix-en-Provence, France-based company’s Aixplorer MultiWave technology, in addition to developing new clinical applications for its products, according to the company.
The Aixplorer ultrasound system images two sound waves "to better characterize tissue," according to the company. It was initially designed for breast exams, but the company plans to develop liver, thyroid, abdominal, musculoskeletal, gynecological and prostate imaging applications for the device.
The company had originally set out to raise €25 million, or $32.8 million, but investors oversubscribed the round to raise the $45.3 million, said CEO Jacques Souquet in prepared remarks.
“These funds transform the financial situation of SuperSonic Imagine and give us the means to accelerate our R&D and to penetrate key commercial markets,” he said.
More than one third of the funding, or €15.5 million, came from new investors Canon Inc. (NYSE:CAJ), InnoBio and Mérieux Développement, which led the round. Previous investors Edmond de Rothschild Investment Partners, Auriga Partners, Crédit Agricole Private Equity, NBGI Ventures, BioAm, Wellington Partners and IXO Private Equity provided the remaining €19 million.
Bedford, Mass.-based Hologic Inc. (NSDQ:HOLX) announced last week that it entered into an exclusive agreement with SuperSonic Imagine S.A. Under the terms of the agreement, Hologic will sell, install and service the company’s Aixplorer ultrasound platform to its U.S. customers.